MM
Morgan Michel
Answers (6)
MM
Answered
All ICD-10 codes begin with a(n) ________ character.
On Jul 10, 2024
alpha alphabetic
MM
Answered
Which of the following is the nation's largest network of institutional healthcare providers?
A) American Hospital Association
B) American Medical Association
C) American Pharmacists Association
D) American College of Physicians
E) American Association of Medical Assistants
A) American Hospital Association
B) American Medical Association
C) American Pharmacists Association
D) American College of Physicians
E) American Association of Medical Assistants
On Jul 07, 2024
A
MM
Answered
What is the correct code assigned for a patient with abetalipoproteinemia?
A) E78.0
B) E78.1
C) E78.5
D) E78.6
A) E78.0
B) E78.1
C) E78.5
D) E78.6
On Jun 10, 2024
D
MM
Answered
Which part of the ear is the most complex?
A) Inner ear
B) Middle ear
C) External ear
D) All of these
A) Inner ear
B) Middle ear
C) External ear
D) All of these
On Jun 07, 2024
A
MM
Answered
Fran is in the medical office because of a painful swelling at the edge of her eye. The physician examines it and tells her it is a sty. Which of the following statements might you include in your patient education for Fran?
A) "Sty is caused by the same skin condition that causes dandruff."
B) "The best thing to do is wait until it forms a white head and then pop it."
C) "Applying warm, moist compresses may help the sty drain sooner."
D) "To prevent sty in the future, stay away from dust, smoke, wind, and excessive glare."
E) "We can irrigate the eye to help relieve the irritation from the sty."
A) "Sty is caused by the same skin condition that causes dandruff."
B) "The best thing to do is wait until it forms a white head and then pop it."
C) "Applying warm, moist compresses may help the sty drain sooner."
D) "To prevent sty in the future, stay away from dust, smoke, wind, and excessive glare."
E) "We can irrigate the eye to help relieve the irritation from the sty."
On May 11, 2024
C
MM
Answered
What is the probability of dying in those who did not die during the 25- to 36-month interval? Use the following table to answer the question. Survival of Patients With Metastatic Cancer Z Following Diagnosis
Interval since beginning treatment (months) Alive at beginning of interval Died during interva 1 Withdre w during interval Effective number exposed to risk of dying Proporti on who died during interval Proportion who did not die during interval Cumulative proportion who survived from enrollment to end of interval xIxdxWxIx′qxpxPx1−12200104013−24150203025−36100302037−48504010\begin{array}{|l|l|l|l|l|l|l|l|}\hline \begin{array}{l}\text { Interval } \\\text { since } \\\text { beginning } \\\text { treatment } \\\text { (months) }\end{array} & \begin{array}{l}\text { Alive at } \\\text { beginning } \\\text { of } \\\text { interval }\end{array} & \begin{array}{l}\text { Died } \\\text { during } \\\text { interva } \\1\end{array} & \begin{array}{l}\text { Withdre } \\\text { w during } \\\text { interval }\end{array} & \begin{array}{l}\text { Effective } \\\text { number } \\\text { exposed } \\\text { to risk of } \\\text { dying }\end{array} & \begin{array}{l}\text { Proporti } \\\text { on who } \\\text { died } \\\text { during } \\\text { interval }\end{array} & \begin{array}{l}\text { Proportion } \\\text { who did not } \\\text { die during } \\\text { interval }\end{array} & \begin{array}{l}\text { Cumulative } \\\text { proportion } \\\text { who } \\\text { survived } \\\text { from } \\\text { enrollment } \\\text { to end of } \\\text { interval }\end{array} \\\hline x & I_{x} & d_{x} & W_{x} & I_{x}^{\prime} & q_{x} & p_{x} & P_{x} \\\hline 1-12 & 200 & 10 & 40 & & & & \\\hline 13-24 & 150 & 20 & 30 & & & & \\\hline 25-36 & 100 & 30 & 20 & & & & \\\hline 37-48 & 50 & 40 & 10 & & & & \\\hline\end{array} Interval since beginning treatment (months) x1−1213−2425−3637−48 Alive at beginning of interval Ix20015010050 Died during interva 1dx10203040 Withdre w during interval Wx40302010 Effective number exposed to risk of dying Ix′ Proporti on who died during interval qx Proportion who did not die during interval px Cumulative proportion who survived from enrollment to end of interval Px
A) 0.30
B) 0.33
C) 0.38
D) 0.67
E) 0.70
Interval since beginning treatment (months) Alive at beginning of interval Died during interva 1 Withdre w during interval Effective number exposed to risk of dying Proporti on who died during interval Proportion who did not die during interval Cumulative proportion who survived from enrollment to end of interval xIxdxWxIx′qxpxPx1−12200104013−24150203025−36100302037−48504010\begin{array}{|l|l|l|l|l|l|l|l|}\hline \begin{array}{l}\text { Interval } \\\text { since } \\\text { beginning } \\\text { treatment } \\\text { (months) }\end{array} & \begin{array}{l}\text { Alive at } \\\text { beginning } \\\text { of } \\\text { interval }\end{array} & \begin{array}{l}\text { Died } \\\text { during } \\\text { interva } \\1\end{array} & \begin{array}{l}\text { Withdre } \\\text { w during } \\\text { interval }\end{array} & \begin{array}{l}\text { Effective } \\\text { number } \\\text { exposed } \\\text { to risk of } \\\text { dying }\end{array} & \begin{array}{l}\text { Proporti } \\\text { on who } \\\text { died } \\\text { during } \\\text { interval }\end{array} & \begin{array}{l}\text { Proportion } \\\text { who did not } \\\text { die during } \\\text { interval }\end{array} & \begin{array}{l}\text { Cumulative } \\\text { proportion } \\\text { who } \\\text { survived } \\\text { from } \\\text { enrollment } \\\text { to end of } \\\text { interval }\end{array} \\\hline x & I_{x} & d_{x} & W_{x} & I_{x}^{\prime} & q_{x} & p_{x} & P_{x} \\\hline 1-12 & 200 & 10 & 40 & & & & \\\hline 13-24 & 150 & 20 & 30 & & & & \\\hline 25-36 & 100 & 30 & 20 & & & & \\\hline 37-48 & 50 & 40 & 10 & & & & \\\hline\end{array} Interval since beginning treatment (months) x1−1213−2425−3637−48 Alive at beginning of interval Ix20015010050 Died during interva 1dx10203040 Withdre w during interval Wx40302010 Effective number exposed to risk of dying Ix′ Proporti on who died during interval qx Proportion who did not die during interval px Cumulative proportion who survived from enrollment to end of interval Px
A) 0.30
B) 0.33
C) 0.38
D) 0.67
E) 0.70
On May 08, 2024
D